Automated gait analysis in bilateral Parkinsonian rats and the role of l-DOPA therapy

Behavioural Brain Research

Volumn 226, Issue 2, 2012, Pages 519-528

  Westin, J E ^a   Janssen, M L F ^b,c   Sager, T N ^a   Temel, Y ^b,c  

^a H LUNDBECK A S   (Denmark)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c European Graduate School of Neuroscience   (Netherlands)

Author keywords

6 OHDA; CatWalk; Gait; L DOPA; Parkinson's disease

Indexed keywords

DOPAMINE; LEVODOPA; MONOAMINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATWALK TEST; CELL COUNT; CONTROLLED STUDY; COORDINATION; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; FORELIMB; GAIT; GAIT DISORDER; HINDLIMB; MALE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SINGLE DRUG DOSE; SURVIVAL RATE;

ANIMALS; CELL COUNT; CORPUS STRIATUM; DOPAMINE; GAIT; HUMANS; LEVODOPA; MALE; MEDIAL FOREBRAIN BUNDLE; NOREPINEPHRINE; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, INBRED STRAINS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 81355133252     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.10.006     Document Type: Article

References (60)

1. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
2. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
3. Devos D., Defebvre L., Bordet R. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease. Fundam Clin Pharmacol 2010, 24:407-421.
4. Karachi C., Grabli D., Bernard F.A., Tande D., Wattiez N., Belaid H., et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 2010, 120:2745-2754.
5. Zarow C., Lyness S.A., Mortimer J.A., Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 2003, 60:337-341.
6. Tan S.K., Hartung H., Sharp T., Temel Y. Serotonin-dependent depression in Parkinson's disease: a role for the subthalamic nucleus?. Neuropharmacology 2011.
7. Hornykiewicz O. Brain monoamines and Parkinsonism. Psychopharmacol Bull 1975, 11:34-35.
8. Marsden C.D. Parkinson's disease. Lancet 1990, 335:948-952.
9. Yuan H., Zhang Z.W., Liang L.W., Shen Q., Wang X.D., Ren S.M., et al. Treatment strategies for Parkinson's disease. Neurosci Bull 2010, 26:66-76.
10. Williams A., Gill S., Varma T., Jenkinson C., Quinn N., Mitchell R., et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010, 9:581-591.
11. Pullman S.L., Watts R.L., Juncos J.L., Chase T.N., Sanes J.N. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology 1988, 38:249-254.
12. Browner N., Giladi N. What can we learn from freezing of gait in Parkinson's disease?. Curr Neurol Neurosci Rep 2010, 10:345-351.
13. Morris M.E., Iansek R., Matyas T.A., Summers J.J. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain 1994, 117(Pt 5):1169-1181.
14. Blin O., Ferrandez A.M., Serratrice G. Quantitative analysis of gait in Parkinson patients: increased variability of stride length. J Neurol Sci 1990, 98:91-97.
15. Wenning G.K., Ebersbach G., Verny M., Chaudhuri K.R., Jellinger K., McKee A., et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov Disord 1999, 14:947-950.
16. Kemoun G., Defebvre L. Gait disorders in Parkinson disease. Gait freezing and falls: therapeutic management. Presse Med 2001, 30:460-468.
17. Cenci M.A., Ohlin K.E. Rodent models of treatment-induced motor complications in Parkinson's disease. Parkinsonism Relat Disord 2009, 15(Suppl. 4):S13-S17.
18. Meredith G.E., Totterdell S., Potashkin J.A., Surmeier D.J. Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 2008, 14(Suppl. 2):S112-S115.
19. Taylor T.N., Greene J.G., Miller G.W. Behavioral phenotyping of mouse models of Parkinson's disease. Behav Brain Res 2010, 211:1-10.
20. Cenci M.A., Whishaw I.Q., Schallert T. Animal models of neurological deficits: how relevant is the rat?. Nat Rev Neurosci 2002, 3:574-579.
21. Shi L.H., Woodward D.J., Luo F., Anstrom K., Schallert T., Chang J.Y. High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions. Brain Res 2004, 1013:98-106.
22. Tillerson J.L., Cohen A.D., Philhower J., Miller G.W., Zigmond M.J., Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. J Neurosci 2001, 21:4427-4435.
23. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999, 19:3248-3257.
24. Chang J.Y., Shi L.H., Luo F., Woodward D.J. High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats. Brain Res 2003, 983:174-184.
25. Mazarakis N.K., Cybulska-Klosowicz A., Grote H., Pang T., Van Dellen A., Kossut M., et al. Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice. J Neurosci 2005, 25:3059-3066.
26. Shi L.H., Luo F., Woodward D.J., Chang J.Y. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test. Synapse 2006, 59:445-457.
27. Amende I., Kale A., McCue S., Glazier S., Morgan J.P., Hampton T.G. Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. J Neuroeng Rehabil 2005, 2:20.
28. Fleming S.M., Salcedo J., Fernagut P.O., Rockenstein E., Masliah E., Levine M.S., et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 2004, 24:9434-9440.
29. Klein A., Wessolleck J., Papazoglou A., Metz G.A., Nikkhah G. Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats. Behav Brain Res 2009, 199:317-325.
30. Metz G.A., Whishaw I.Q. Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination. J Neurosci Methods 2002, 115:169-179.
31. Metz G.A., Whishaw I.Q. The ladder rung walking task: a scoring system and its practical application. J Vis Exp 2009.
32. de Medinaceli L., Freed W.J., Wyatt R.J. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp Neurol 1982, 77:634-643.
33. Metz G.A., Tse A., Ballermann M., Smith L.K., Fouad K. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis. Eur J Neurosci 2005, 22:735-744.
34. Hamers F.P., Lankhorst A.J., van Laar T.J., Veldhuis W.B., Gispen W.H. Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma 2001, 18:187-201.
35. Gabriel A.F., Marcus M.A., Honig W.M., Walenkamp G.H., Joosten E.A. The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods 2007, 163:9-16.
36. Gabriel A.F., Marcus M.A., Walenkamp G.H., Joosten E.A. The CatWalk method: assessment of mechanical allodynia in experimental chronic pain. Behav Brain Res 2009, 198:477-480.
37. Deumens R., Jaken R.J., Marcus M.A., Joosten E.A. The CatWalk gait analysis in assessment of both dynamic and static gait changes after adult rat sciatic nerve resection. J Neurosci Methods 2007, 164:120-130.
38. Gensel J.C., Tovar C.A., Hamers F.P., Deibert R.J., Beattie M.S., Bresnahan J.C. Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J Neurotrauma 2006, 23:36-54.
39. Hamers F.P., Koopmans G.C., Joosten E.A. CatWalk-assisted gait analysis in the assessment of spinal cord injury. J Neurotrauma 2006, 23:537-548.
40. Koopmans G.C., Deumens R., Honig W.M., Hamers F.P., Steinbusch H.W., Joosten E.A. The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. J Neurotrauma 2005, 22:214-225.
41. Vandeputte C., Taymans J.M., Casteels C., Coun F., Ni Y., Van Laere K., et al. Automated quantitative gait analysis in animal models of movement disorders. BMC Neurosci 2010, 11:92.
42. Chuang C.S., Su H.L., Cheng F.C., Hsu S.H., Chuang C.F., Liu C.S. Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson's disease. J Biomed Sci 2010, 17:9.
43. Vlamings R., Visser-Vandewalle V., Koopmans G., Joosten E.A., Kozan R., Kaplan S., et al. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats. Neuroscience 2007, 148:815-823.
44. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press Inc., San Diego, CA.
45. Temel Y., Visser-Vandewalle V., Aendekerk B., Rutten B., Tan S., Scholtissen B., et al. Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus. Exp Neurol 2005, 193:43-52.
46. Schmitz C., Hof P.R. Design-based stereology in neuroscience. Neuroscience 2005, 130:813-831.
47. Koopmans G.C., Deumens R., Brook G., Gerver J., Honig W.M., Hamers F.P., et al. Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol Behav 2007, 92:993-1001.
48. Srinivasan J., Schmidt W.J. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease. Behav Brain Res 2004, 151:191-199.
49. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
50. Yavich L., Sirvio J., Haapalinna A., Ylinen A., Mannisto P.T. Atipamezole, an alpha2-adrenoceptor antagonist, augments the effects of l-DOPA on evoked dopamine release in rat striatum. Eur J Pharmacol 2003, 462:83-89.
51. Gerlach M., Jellinger K., Riederer P. The possible role of noradrenergic deficits in selected signs of Parkinson's Disease 1994, CRC Press, pp. 59-72.
52. Blin O., Ferrandez A.M., Pailhous J., Serratrice G. Dopa-sensitive and dopa-resistant gait parameters in Parkinson's disease. J Neurol Sci 1991, 103:51-54.
53. Knutsson E. An analysis of Parkinsonian gait. Brain 1972, 95:475-486.
54. Stern G.M., Franklyn S.E., Imms F.J., Prestidge S.P. Quantitative assessments of gait and mobility in Parkinson's disease. J Neural Transm Suppl 1983, 19:201-214.
55. Krystkowiak P., Blatt J.L., Bourriez J.L., Duhamel A., Perina M., Kemoun G., et al. Chronic bilateral pallidal stimulation and levodopa do not improve gait in the same way in Parkinson's disease: a study using a video motion analysis system. J Neurol 2001, 248:944-949.
56. Kemoun G., Defebvre L. Gait disorders in Parkinson disease. Clinical description, analysis of posture, initiation of stabilized gait. Presse Med 2001, 30:452-459.
57. Klapka N., Hermanns S., Straten G., Masanneck C., Duis S., Hamers F.P., et al. Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci 2005, 22:3047-3058.
58. Klawans H.L. Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord 1986, 1:187-192.
59. Cenci M.A., Lee C.S., Bjorklund A. l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 1998, 10:2694-2706.
60. Lubik S., Fogel W., Tronnier V., Krause M., Konig J., Jost W.H. Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation. J Neural Transm 2006, 113:163-173.